Adage Capital Partners’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
FLAM
RSCM
PAMP
Adage Capital Partners's XENT Position: Q2 2021 in Review
Adage Capital Partners sold out of Intersect ENT, Inc (XENT) in Q2 2021, closing a stake of 500,000 shares — an estimated $10.4M sold.
Adage Capital Partners first reported a position in XENT in Q3 2014 and held it in 18 quarters. The position peaked at $28.6M in Q4 2019. 107 funds tracked by Wall St. Rank hold XENT as of Q2 2021.
- Adage Capital Partners reported no remaining Intersect ENT, Inc position as of Q2 2021 after selling out during the quarter.
- Adage Capital Partners sold 500,000 Intersect ENT, Inc shares in Q2 2021, an estimated $10.4M.
- Adage Capital Partners first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 18 quarters.
- Adage Capital Partners's Intersect ENT, Inc position peaked at $28.6M in Q4 2019.
- 107 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2021.
Based on Adage Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.